Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI.

Severe asthma biomarkers female male obesity sex smoking type 2

Journal

Allergy, asthma & immunology research
ISSN: 2092-7355
Titre abrégé: Allergy Asthma Immunol Res
Pays: Korea (South)
ID NLM: 101518382

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 10 04 2020
revised: 06 06 2020
accepted: 22 06 2020
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 22 1 2021
Statut: ppublish

Résumé

After adolescence, asthma is more frequent in females than in males due to different hormonal, immunologic, and occupational/environmental factors. The higher prevalence and severity of the disease in females have already been reported in international registries. The aim of this study was to explore the difference in terms of clinical, functional, and biological characteristics between male and female patients with severe asthma in a real-life, registry-based setting. Baseline data from the Severe Asthma Network in Italy registry were analyzed in 1,123 patients with severe asthma, according to sex. Almost 2/3 of severe asthmatics were female. Late-onset asthma, obesity and gastro-esophageal reflux were more frequent in females than in males, while previous smoking habits and nasal polyposis were more frequent in males. Females had poor asthma control and a higher number of severe exacerbations leading to hospitalization, in comparison to males. Biomarkers of type 2 inflammation (blood eosinophil, exhaled nitric oxide, and serum immunoglobulin E levels) were significantly higher in males than in females. The type 2 profile (defined by a combination of these 3 biomarkers) was significantly more frequent in males than in females. In multivariate analysis, late-onset asthma and a normal body mass index were only independent variables associated with the type 2 profile, while male sex and age showed only a trend toward the association with the type 2 profile. Significant differences may be observed between male and female patients with severe asthma, influencing the asthma pheno-endotyping in both sexes.

Identifiants

pubmed: 33474857
pii: 13.219
doi: 10.4168/aair.2021.13.2.219
pmc: PMC7840868
doi:

Types de publication

Journal Article

Langues

eng

Pagination

219-228

Subventions

Organisme : AstraZeneca
Pays : Italy
Organisme : GlaxoSmithKline
Pays : Italy
Organisme : Novartis and Sanofi
Pays : Italy

Informations de copyright

Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.

Déclaration de conflit d'intérêts

There are no financial or other issues that might lead to conflict of interest.

Références

Clin Mol Allergy. 2017 Apr 10;15:9
pubmed: 28400707
Allergy Asthma Clin Immunol. 2019 Nov 6;15:65
pubmed: 31708980
Immunohorizons. 2018 Feb;2(2):74-86
pubmed: 29568816
Allergy Asthma Immunol Res. 2018 Jul;10(4):387-396
pubmed: 29949835
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Respirology. 2013 Jul;18(5):797-806
pubmed: 23490273
J Exp Med. 2017 Jun 5;214(6):1581-1592
pubmed: 28484078
J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1462-1468
pubmed: 30368004
Am J Physiol Lung Cell Mol Physiol. 2020 Jan 1;318(1):L112-L124
pubmed: 31617730
Am J Respir Crit Care Med. 2012 Feb 15;185(4):356-62
pubmed: 22095547
PLoS One. 2016 Jun 13;11(6):e0157301
pubmed: 27294365
Respir Med. 2017 Sep;130:85-91
pubmed: 29206638
Int J Mol Sci. 2020 Feb 24;21(4):
pubmed: 32102344
J Allergy Clin Immunol. 2014 May;133(5):1280-8
pubmed: 24589344
ERJ Open Res. 2019 Dec 02;5(4):
pubmed: 31803772
J Allergy Clin Immunol. 2010 Sep;126(3):498-504.e1-6
pubmed: 20816186
J Allergy Clin Immunol. 2012 Aug;130(2):332-42.e10
pubmed: 22694932
J Allergy Clin Immunol. 2007 Jun;119(6):1337-48
pubmed: 17416409
Respir Med. 2014 Dec;108(12):1723-32
pubmed: 25456708
Ann Allergy Asthma Immunol. 2003 Dec;91(6):553-8
pubmed: 14700439
Chest. 2013 Feb 1;143(2):406-414
pubmed: 23064546
Eur Respir J. 2020 Jan 9;55(1):
pubmed: 31601713
Allergy. 2018 Mar;73(3):683-695
pubmed: 29072882
Clin Mol Allergy. 2018 Dec 3;16:25
pubmed: 30524206
Clin Chest Med. 2019 Mar;40(1):149-161
pubmed: 30691709
Eur Respir J. 2013 Oct;42(4):1012-9
pubmed: 23349447
Chest. 2020 Apr;157(4):790-804
pubmed: 31785254
Allergy Asthma Immunol Res. 2019 Jan;11(1):43-54
pubmed: 30479076
BMC Public Health. 2012 Mar 19;12:204
pubmed: 22429515
Cell Rep. 2017 Nov 28;21(9):2487-2499
pubmed: 29186686
J Immunol. 2018 Oct 1;201(7):1843-1854
pubmed: 30127088
Respir Med. 2020 Feb;162:105858
pubmed: 31916535

Auteurs

Gianenrico Senna (G)

Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.

Manuela Latorre (M)

Department of Surgery, Medicine and Molecular Biology and Critical Care, Nuovo Ospedale Apuano, University of Pisa, Pisa, Italy.

Massimo Bugiani (M)

Pneumology and Tisiology Unit, National Health Service (ASL TO2), Turin, Italy.

Marco Caminati (M)

Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.

Enrico Heffler (E)

Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Daniela Morrone (D)

Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Giovanni Paoletti (G)

Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Paola Parronchi (P)

Department of Clinical and Experimental Medicine,University of Florence, Florence, Italy.

Francesca Puggioni (F)

Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Francesco Blasi (F)

Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Giorgio Walter Canonica (GW)

Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Pierluigi Paggiaro (P)

Department of Surgery, Medicine and Molecular Biology and Critical Care, Nuovo Ospedale Apuano, University of Pisa, Pisa, Italy. pierluigi.paggiaro@unipi.it.

Classifications MeSH